tirzepatide removed from fda shortage list Announced Removal of the Drug Eli Lilly's weight loss drugs

The potential benefits of tirzepatide may include the following: Significant and sustained weight loss Tirzepatide is a dual GLP-1/GIP receptor agonist that helps significantly reduce body weight by enhancing insulin secretion, lowering glucagon levels, and delaying gastric emptying, which contribute to reduced calorie intake and weight loss

Disclaimer This article is for educational and journalistic purposes only

Within-group comparisons were performed using the paired t test

follow label directions and contact a clinician when in doubt

Any delays in phase 3 results, safety signals, or manufacturing readiness could push the timeline further back